Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study

Background: Epigenetic clocks have been associated with cancer risk in several observational studies. Nevertheless, it is unclear whether they play a causal role in cancer risk or if they act as a non-causal biomarker. Methods: We conducted a two-sample Mendelian randomization (MR) study to examine...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fernanda Morales Berstein, Daniel L McCartney, Ake T Lu, Konstantinos K Tsilidis, Emmanouil Bouras, Philip Haycock, Kimberley Burrows, Amanda I Phipps, Daniel D Buchanan, Iona Cheng, the PRACTICAL consortium, Richard M Martin, George Davey Smith, Caroline L Relton, Steve Horvath, Riccardo E Marioni, Tom G Richardson, Rebecca C Richmond
Format: Artigo
Idioma:Inglês
Publicat: eLife Sciences Publications Ltd 2022-03-01
Col·lecció:eLife
Matèries:
cancer
epigenetic age acceleration
Mendelian randomization
epigenetic clocks
epidemiology
DNA methylation
Accés en línia:https://elifesciences.org/articles/75374
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars